M Fiegl|W Hiddemann - JoVE Visualize

Showing results (131-140 of 414) with videos related to

Pageof 42

Sort By:

Leukemia & Lymphoma|October 29, 2002

Diffuse large B-cell lymphoma with infiltration-associated peripheral neuropathy and paraneoplastic myopathy with a prolonged course over seven yearsM Fiegl, A Muigg, A Smekal, et al.

Journal of Clinical Pathology|January 6, 2006

Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000T Mitterlechner, M Fiegl, H Mühlböck, et al.

Annals of Hematology|August 31, 1999

Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literatureM Fiegl, A Weltermann, R Stindl, et al.

Lung Cancer (Amsterdam, Netherlands)|January 14, 2014

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patientA Pircher, C Manzl, M Fiegl, et al.

Blut|June 20, 1978

[Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]T h Büchner, D Kamanabroo, D Urbanitz, et al.

Der Internist|June 15, 2006

[Risk-adapted therapy of acute myeloid leukemia]W Hiddemann, K Spiekermann, J Braess, et al.

Acta Haematologica|August 7, 1999

Hypercoagulability in a patient with hypodysfibrinogenemia: implications for clinical managementG G Wulf, M Unterhalt, A Buchwald, et al.

Anticancer Research|March 28, 2001

Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotectionW Kern, J Braess, C C Kaufmann, et al.

Best Practice & Research. Clinical Haematology|May 18, 2001

Acute myeloid leukaemia (AML): treatment of the older patientT Büchner, W Hiddemann, C Schoch, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1996

A cell-surface epitope associated with liver-preferential metastasis detected by the new monoclonal antibody 3H4 in the murine tumor model ER 15-PG G Wulf, G Edel, B Deneke, et al.

Pageof 42

Showing results (131-140 of 414) with videos related to

Sort By:

Pageof 42

Leukemia & Lymphoma|October 29, 2002

Diffuse large B-cell lymphoma with infiltration-associated peripheral neuropathy and paraneoplastic myopathy with a prolonged course over seven yearsM Fiegl, A Muigg, A Smekal, et al.

Journal of Clinical Pathology|January 6, 2006

Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000T Mitterlechner, M Fiegl, H Mühlböck, et al.

Annals of Hematology|August 31, 1999

Massive disseminated intravascular coagulation and hyperfibrinolysis in alveolar rhabdomyosarcoma: case report and review of the literatureM Fiegl, A Weltermann, R Stindl, et al.

Lung Cancer (Amsterdam, Netherlands)|January 14, 2014

Overcoming resistance to first generation EGFR TKIs with cetuximab in combination with chemotherapy in an EGFR mutated advanced stage NSCLC patientA Pircher, C Manzl, M Fiegl, et al.

Blut|June 20, 1978

[Clinical and cell kinetic data on the combination of cytosine arabinoside with daunorubicin, isosfamide, thioguanine, and vincristine for remission induction and maintenance in patients with acute myelocytic leukaemia (author's transl)]T h Büchner, D Kamanabroo, D Urbanitz, et al.

Der Internist|June 15, 2006

[Risk-adapted therapy of acute myeloid leukemia]W Hiddemann, K Spiekermann, J Braess, et al.

Acta Haematologica|August 7, 1999

Hypercoagulability in a patient with hypodysfibrinogenemia: implications for clinical managementG G Wulf, M Unterhalt, A Buchwald, et al.

Anticancer Research|March 28, 2001

Microalbuminuria during cisplatin therapy: relation with pharmacokinetics and implications for nephroprotectionW Kern, J Braess, C C Kaufmann, et al.

Best Practice & Research. Clinical Haematology|May 18, 2001

Acute myeloid leukaemia (AML): treatment of the older patientT Büchner, W Hiddemann, C Schoch, et al.

Journal of Cancer Research and Clinical Oncology|January 1, 1996

A cell-surface epitope associated with liver-preferential metastasis detected by the new monoclonal antibody 3H4 in the murine tumor model ER 15-PG G Wulf, G Edel, B Deneke, et al.

Pageof 42